查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494747

到 2030 年獸醫保健市場預測：按產品、疾病、最終用戶和地區進行的全球分析

Veterinary Healthcare Market Forecasts to 2030 - Global Analysis By Product, Disease, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球獸醫保健市場規模為 460.7 億美元，預計預測期內複合年成長率為 11.11%，到 2030 年將達到 866.9 億美元。

獸醫保健涵蓋頻譜的醫療服務，旨在促進動物的福祉和健康。包括針對各種動物物種（包括寵物、牲畜、野生動物和異國風動物）的預防措施、診斷、治療和復原。獸醫透過其在外科、內科、牙科、營養、行為等方面的專業知識，在保護動物福利、公共衛生和環境方面發揮重要作用。其職責不僅限於照顧個別動物，還包括疾病控制、疫苗接種計劃以及旨在推進醫學知識和改善醫療保健結果的研究。

根據美國寵物產品協會的數據，獸醫支出正在穩步成長，2021 年美國消費者在獸醫護理和產品銷售上的支出為 1,236 億美元。

寵物保險增加

隨著越來越多的人購買寵物保險，即使在非緊急情況下也越來越希望去看獸醫。這項變更減少了可能阻礙飼主為其動物接受預防性和定期治療的經濟障礙。因此，獸醫可以增加患者數量，投資先進的設備、設施和培訓，並提高整體護理品質。此外，保險範圍鼓勵飼主遵守治療計劃和後續觀察預約，從而改善寵物的健康狀況。

景氣衰退

景氣衰退可能對獸醫保健市場產生重大影響。在經濟狀況，寵物飼主可能會削減非必要開支，包括獸醫護理、選擇更便宜的替代療法或推遲定期就診。因此，對獸醫服務和產品的需求將減少，最終影響獸醫院和製藥公司的收益。然而，由於經濟不確定性，消費者推遲或放棄購買新寵物，需求可能會進一步下降。

動物醫學的進展

MRI 和電腦斷層掃描等先進影像技術等創新技術可以更準確地診斷動物的複雜疾病狀況。藥物開發提供了更有效、副作用更少的藥物，改善了動物的治療結果和生活品質。此外，微創手術技術透過減少恢復時間和術後併發症進一步推動獸醫學的發展。整合遠端醫療可以實現遠端諮詢和監控，改善獸醫服務的獲取，特別是在服務不足的地區。

獸醫短缺

提供護理的專業人員數量的減少將增加現有獸醫的負擔，增加預約的等待時間，減少獲得獸醫服務的機會，並使從業人員更加忙碌，提供護理的能力可能會下降。然而，獸醫短缺也限制了獸醫診所向服務不足地區的擴張，加劇了伴同性動物和牲畜獲得醫療保健的不平等。缺乏能夠推動研究和實施進步的專家限制了該領域創新療法和技術的開發和實施。

COVID-19 的影響：

COVID-19 大流行對獸醫保健市場產生了重大影響。我們看到寵物飼主的行為發生了顯著變化，許多人花更多時間待在家裡，鎖上門，並且更加關注寵物的健康和福祉。寵物擁有量的迅速增加以及對寵物健康的關注導致對預防保健、疫苗接種和遠端醫療諮詢等獸醫服務的需求增加。然而，法規和安全措施暫時關閉了一些獸醫診所並減少了親自就診，影響了常規和非緊急護理。

預計過敏領域在預測期內將是最大的。

預計過敏領域在預測期內將是最大的。隨著全球寵物數量的增加，人們對寵物健康問題（包括過敏）的認知也隨之提高。這種認知導致了對專用針對寵物的過敏治療、診斷和低過敏產品的研發投資的增加。獸醫醫院正在擴大服務範圍，包括過敏測試和治療選擇，吸引了為毛茸茸的同伴尋求全面護理的飼主。此外，製藥公司正在推出針對寵物過敏的新藥和疫苗，進一步推動市場成長。

預計獸醫醫院產業在預測期內的複合年成長率最高。

獸醫醫院部門預計在預測期內將出現最高的複合年成長率，因為它為各種動物物種（包括寵物、牲畜和異國風動物）提供廣泛的專業藥品、補充品和其他保健產品。透過專注於動物用藥品，這些藥房確保獲得傳統人類藥房可能無法輕易獲得的重要藥物。此外，獸醫藥房通常僱用具有動物健康專業知識的員工，他們可以為寵物飼主和牲畜生產者提供個人化的指導和建議。

比最大的地區

北美地區將成為整個估計期間最大的市場佔有率。獸醫醫院的區域擴張不僅改善了動物獲得優質醫療保健的機會，而且促進了獸醫醫學的創新。這些醫院注重預防性護理、早期發現和先進治療，為該地區的獸醫護理制定了標準。

複合年成長率最高的地區：

透過確保動物用藥品和服務的安全性、有效性和質量，預計亞太地區將在預測期內實現有益成長。政府法規通常包括動物用藥品和保健產品的註冊、生產、分銷和銷售指南。透過執行嚴格的監管標準，政府提高了產業內的透明度和課責，並增強了全部區域消費者和相關人員的信心。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球獸醫保健市場：依產品

  • 治療藥物/藥品
  • 診斷工具
  • 其他產品

第6章全球獸醫保健市場：依疾病分類

  • 消化系統疾病
  • 過敏
  • 關節炎

第7章 全球獸醫保健市場：依最終使用者分類

  • 獸醫藥房
  • 獸醫院
  • 其他最終用戶

第8章全球獸醫保健市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • Zoetis Animal Healthcare
  • Ceva Animal Health Inc
  • Elanco Animal Health
  • Phibro Animal Health
  • Boehringer Ingelheim International GmbH
  • SeQuent Scientific Ltd
  • Cargill Inc
  • MSD Animal Health
  • Sanofi-Aventis
  • Bayer Healthcare
  • Novartis International AG
Product Code: SMRC26262

According to Stratistics MRC, the Global Veterinary Healthcare Market is accounted for $46.07 billion in 2024 and is expected to reach $86.69 billion by 2030 growing at a CAGR of 11.11% during the forecast period. Veterinary healthcare encompasses a broad spectrum of medical services aimed at promoting the well-being and health of animals. It involves preventive measures, diagnostics, treatment, and rehabilitation for various animal species, including pets, livestock, wildlife, and exotic animals. Veterinarians play a crucial role in safeguarding animal welfare, public health, and the environment through their expertise in areas such as surgery, internal medicine, dentistry, nutrition, and behavior. Their responsibilities extend beyond individual animal care to disease control, vaccination programs, and research aimed at advancing medical knowledge and improving healthcare outcomes.

According to the American Pet Products Association, veterinary care spending has been steadily rising, with U.S. consumers spent US$ 123.6 billion in 2021 on veterinarian care and product sales.

Market Dynamics:

Driver:

Rise in pet insurance coverage

With more individuals opting for pet insurance plans, there's an increased willingness to seek veterinary care, even for non-emergency situations. This shift reduces financial barriers that might otherwise deter pet owners from seeking preventive or routine medical attention for their animals. Consequently, veterinarians experience higher patient volumes, enabling them to invest in advanced equipment, facilities, and training, thereby elevating the overall quality of care. Moreover, insurance coverage incentivizes pet owners to adhere to treatment plans and follow-up appointments, leading to better health outcomes for their pets.

Restraint:

Economic downturns

Economic downturns can significantly impact the veterinary healthcare market. During tough economic times, pet owners may cut back on non-essential expenditures, including veterinary care, opting for cheaper alternatives or delaying routine visits. This leads to reduced demand for veterinary services and products, ultimately affecting the revenue streams of veterinary clinics and pharmaceutical companies. However, economic uncertainty may prompt consumers to postpone or forego adopting new pets, further dampening demand.

Opportunity:

Advancements in veterinary medicine

Innovations such as advanced imaging technologies like MRI and CT scans enable more accurate diagnoses of complex conditions in animals. Developments in pharmaceuticals have led to the availability of more effective medications with fewer side effects, improving treatment outcomes and quality of life for animals. Moreover, minimally invasive surgical techniques have reduced recovery times and post-operative complications, further advancing veterinary care. The integration of telemedicine allows for remote consultations and monitoring, increasing accessibility to veterinary services, particularly in underserved areas.

Threat:

Shortage of veterinarians

With fewer professionals available to provide care, there's an increased burden on existing veterinarians, leading to longer wait times for appointments, reduced accessibility to veterinary services, and potentially compromised quality of care due to overwhelmed practitioners. However, this shortage also limits the expansion of veterinary practices into underserved areas, exacerbating disparities in access to healthcare for both companion animals and livestock. It restricts the development and adoption of innovative treatments and technologies within the field, as there are fewer experts available to drive research and implement advancements.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the veterinary healthcare market as there was a noticeable shift in pet owner behavior, with many people spending more time at home during lockdowns, leading to increased attention to their pets' health and well-being. This surge in pet ownership and concern for pet health translated into higher demand for veterinary services, including preventive care, vaccinations, and telemedicine consultations. However, on the flip side, restrictions and safety measures also led to temporary closures of some veterinary clinics and reduced in-person visits, affecting routine procedures and non-urgent care.

The Allergies segment is expected to be the largest during the forecast period

Allergies segment is expected to be the largest during the forecast period. As pet ownership rises globally, so does awareness of pet health issues, including allergies. This awareness has led to increased investment in research and development of allergy treatments, diagnostics, and hypoallergenic products tailored specifically for pets. Veterinary clinics are expanding their services to include allergy testing and treatment options, attracting pet owners seeking comprehensive care for their furry companions. Moreover, pharmaceutical companies are introducing new medications and vaccines targeting pet allergies, further fueling market growth.

The Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period

Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period as these pharmacies offer a wide range of medications, supplements, and other healthcare products specifically formulated for various species, including pets, livestock, and exotic animals. By focusing solely on veterinary medications, these pharmacies ensure the availability of essential drugs that may not be readily accessible in traditional human pharmacies. Moreover, veterinary pharmacies often employ staff with expertise in animal health, enabling them to offer personalized guidance and advice to pet owners and livestock producers.

Region with largest share:

North America region is poised to hold the largest market share throughout the estimated period of time as these increasing investments in veterinary hospitals are leading to the establishment of state-of-the-art facilities equipped with advanced diagnostic tools, treatment options, and specialized care services for pets. The regional expansion of veterinary hospitals is not only improving access to quality healthcare for animals but also driving innovation in veterinary medicine. With a focus on preventive care, early detection, and advanced treatments, these hospitals are raising the standard of veterinary healthcare in the region.

Region with highest CAGR:

Asia Pacific region is estimated to gain profitable growth over the extrapolated period by ensuring the safety, efficacy, and quality of veterinary products and services. Government regulations often include guidelines for the registration, manufacturing, distribution, and marketing of veterinary medicines and healthcare products. By enforcing stringent regulatory standards, governments promote transparency and accountability within the industry, fostering trust among consumers and stakeholders across the region.

Key players in the market

Some of the key players in Veterinary Healthcare market include Zoetis Animal Healthcare, Ceva Animal Health Inc, Elanco Animal Health, Phibro Animal Health, Boehringer Ingelheim International GmbH, SeQuent Scientific Ltd, Cargill Inc, MSD Animal Health, Sanofi-Aventis, Bayer Healthcare and Novartis International AG.

Key Developments:

In September 2022, Merck Animal Health announced the new label indication for both Bravectoand BravectoPlus for topical use in cats to treat and control Asian long-horned tick infestations. Bravectoand BravectoPlus for cats is the first and only U.S. product labeled for treatment and control.

In January 2022, Zoetis announced that the U.S. Food and Drug Administration (FDA) had approved a new label indication for SimparicaTrio (sarolaner, moxidectin, and pyrantel chewable tablets) for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks (black-legged or deer ticks). SimparicaTrio is approved for dogs eight weeks of age and older.

Products Covered:

  • Therapeutics/Drugs
  • Diagnostic Tool
  • Other Products

Diseases Covered:

  • Gastrointestinal Diseases
  • Allergies
  • Arthritis

End Users Covered:

  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Veterinary Healthcare Market, By Product

  • 5.1 Introduction
  • 5.2 Therapeutics/Drugs
  • 5.3 Diagnostic Tool
  • 5.4 Other Products

6 Global Veterinary Healthcare Market, By Disease

  • 6.1 Introduction
  • 6.2 Gastrointestinal Diseases
  • 6.3 Allergies
  • 6.4 Arthritis

7 Global Veterinary Healthcare Market, By End User

  • 7.1 Introduction
  • 7.2 Veterinary Pharmacies
  • 7.3 Veterinary Hospitals
  • 7.4 Other End Users

8 Global Veterinary Healthcare Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Zoetis Animal Healthcare
  • 10.2 Ceva Animal Health Inc
  • 10.3 Elanco Animal Health
  • 10.4 Phibro Animal Health
  • 10.5 Boehringer Ingelheim International GmbH
  • 10.6 SeQuent Scientific Ltd
  • 10.7 Cargill Inc
  • 10.8 MSD Animal Health
  • 10.9 Sanofi-Aventis
  • 10.10 Bayer Healthcare
  • 10.11 Novartis International AG

List of Tables

  • Table 1 Global Veterinary Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 4 Global Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 5 Global Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 6 Global Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 7 Global Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 8 Global Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 9 Global Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 10 Global Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 11 Global Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 12 Global Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 13 Global Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 14 North America Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 15 North America Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 16 North America Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 17 North America Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 18 North America Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 19 North America Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 20 North America Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 21 North America Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 22 North America Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 23 North America Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 North America Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 25 North America Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 26 North America Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 27 Europe Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 28 Europe Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 29 Europe Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 30 Europe Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 31 Europe Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 32 Europe Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 33 Europe Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 34 Europe Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 35 Europe Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 36 Europe Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 37 Europe Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 38 Europe Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 39 Europe Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 40 Asia Pacific Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 41 Asia Pacific Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 42 Asia Pacific Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 43 Asia Pacific Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 44 Asia Pacific Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 45 Asia Pacific Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 46 Asia Pacific Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 47 Asia Pacific Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 48 Asia Pacific Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 49 Asia Pacific Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 50 Asia Pacific Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 51 Asia Pacific Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 52 Asia Pacific Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 53 South America Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 54 South America Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 55 South America Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 56 South America Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 57 South America Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 58 South America Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 59 South America Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 60 South America Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 61 South America Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 62 South America Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 63 South America Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 64 South America Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 65 South America Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 66 Middle East & Africa Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
  • Table 67 Middle East & Africa Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
  • Table 68 Middle East & Africa Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
  • Table 69 Middle East & Africa Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
  • Table 70 Middle East & Africa Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 71 Middle East & Africa Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
  • Table 72 Middle East & Africa Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
  • Table 73 Middle East & Africa Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
  • Table 74 Middle East & Africa Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
  • Table 75 Middle East & Africa Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 76 Middle East & Africa Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
  • Table 77 Middle East & Africa Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 78 Middle East & Africa Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)